The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Shpak L.V.

Tverskaia gosudarstvennaia meditsinskaia akademiia, kafedra vnutrennikh bolezneĭ FPDO i kafedra khimii

Zubareva G.M.

Tverskaia gosudarstvennaia meditsinskaia akademiia, kafedra vnutrennikh bolezneĭ FPDO i kafedra khimii

Lebedeva S.N.

Tverskaia gosudarstvennaia meditsinskaia akademiia, kafedra vnutrennikh bolezneĭ FPDO i kafedra khimii

Mexidol influence on the parameters of infrared spectrometry of blood lipid complex in case of acute coronary syndrome

Authors:

Shpak L.V., Zubareva G.M., Lebedeva S.N.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2014;7(3): 12‑17

Read: 1910 times

Download PDF (RU)
Contact the author
Table of contents

MEXIDOL INFLUENCE ON THE PARAMETERS OF INFRARED SPECTROMETRY OF BLOOD LIPID COMPLEX IN CASE OF ACUTE CORONARY SYNDROME
MEXIDOL INFLUENCE ON THE PARAMETERS OF INFRARED SPECTROMETRY OF BLOOD LIPID COMPLEX IN CASE OF ACUTE CORONARY SYNDROME

To cite this article:

Shpak LV, Zubareva GM, Lebedeva SN. Mexidol influence on the parameters of infrared spectrometry of blood lipid complex in case of acute coronary syndrome. Russian Journal of Cardiology and Cardiovascular Surgery. 2014;7(3):12‑17. (In Russ.)

 
ЭндоКард
Подписка 2026 Кардиология и сердечно-сосудистая хирургия (Russian Journal of Cardiology and Cardiovascular Surgery)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
The possibilities of Mexi­dol in the complex therapy of arte­rial hype­rtension. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(5):572-580
Intravascular imaging and physiological asse­ssment of coro­nary blood flow for treatment stra­tegy in patients with acute coro­nary syndrome. Analysis of Russian regi­stry of intravascular imaging and physiological methods in 2021—2022. Russian Cardiology Bulletin. 2024;(3):43-52
In-hospital therapy for myocardial infa­rction in the Russian Fede­ration acco­rding to the REGION-IM regi­stry: compliance with clinical guidelines. Russian Cardiology Bulletin. 2024;(3):81-91
The effect of ethy­lmethylhydroxypyridine succinate on the para­meters of chro­nic neuroinflammation and plastic processes in the brain of old rats during course of dexa­methasone admi­nistration. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(9):115-121
Inte­rnational multicenter randomized double-blind placebo-controlled study asse­ssing the effi­cacy and safety of sequential therapy with Mexi­dol and Mexi­dol FORTE 250 in patients with chro­nic brain ischemia (MEMO): suba­nalysis in patients with arte­rial hype­rtension. Russian Journal of Preventive Medi­cine. 2024;(10):72-83
Modern approaches to diagnosis and treatment of syndrome of auto­nomic dysfunction in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11-2):66-75
Modern aspe­cts of chro­nic cere­bral ischemia pathogenetic therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):106-113
Impact of different forms of outpatient follow-up on survival after acute coro­nary syndrome. Russian Cardiology Bulletin. 2024;(4-2):172-181
Rela­tionship between renal dysfunction, left ventricular diastolic dysfunction and coro­nary athe­rosclerosis in patients with non-ST segment elevation acute coro­nary syndrome. Russian Journal of Preventive Medi­cine. 2025;(1):76-82
Arte­rial hype­rtension is an oxidative stress, as a pathogenetic target for the treatment of chro­nic cere­brovascular insu­fficiency. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):84-90
Abstract:

It was analyzed the mexidol influence on phospholipid metabolism in acute coronary syndrome (ACS). The study included 70 patients. Intravenous mexidol infusions were included in the complex therapy in 30 cases. Conventional clinical and laboratory data, as well as the absorption of lipid phospholipid complexes in the infrared spectrum of blood serum were evaluated. The study established a mechanism of phospholipids autoregulation as a wave-like fluctuations of their concentration in the blood serum with early increasing (compared with healthy) in the first hours and days of development of ACS. It was observed the maximum rise by the 4th day and a moderate decline by the 10 day of observation reflecting the degree of adaptation systems stress. Regardless on the clinical form of ACS mexidol application eliminates oscillatory nature of the phospholipids dynamics. It is stabilizing their rise at a level sufficient to ensure the power and plastic needs of the organism and myocardium that improves the results of combined treatment.

Keywords:

acute coronary syndrome
homeostasis
phospholipids
mexidol
infrared spectrometry

Authors:

Shpak L.V.

Tverskaia gosudarstvennaia meditsinskaia akademiia, kafedra vnutrennikh bolezneĭ FPDO i kafedra khimii

Zubareva G.M.

Tverskaia gosudarstvennaia meditsinskaia akademiia, kafedra vnutrennikh bolezneĭ FPDO i kafedra khimii

Lebedeva S.N.

Tverskaia gosudarstvennaia meditsinskaia akademiia, kafedra vnutrennikh bolezneĭ FPDO i kafedra khimii

Close metadata

References:

  1. Belyakin S.А., Igonin V.А., SHames А.B., Proskurin V.M. Ostryj koronarnyj sindrom: sovremennye podkhody k diagnostike i lecheniyu [Acute coronary syndrome: current approaches to diagnosis and treatment]. Voen-med zhurn 2009; 3: 24-29. (in Russian)
  2. Belousov YU.B., Zyryanov S.K., Syrov А.V. Sravnitel'naya farmakoehkonomicheskaya otsenka ehnoksaparina i nefraktsionnogo geparina pri ostrom koronarnom sindrome bez pod"ema segmenta ST [Comparative pharmacoeconomic evaluation of enoxaparin and unfractionated heparin in acute coronary syndrome without ST segment elevation]. Ros kardiol zhurn 2010; 2: 59-66. (in Russian)
  3. Vereshhagina V.S. Issledovanie nekotorykh aspektov mekhanizma protivoaritmicheskogo dejstviya dimefosfana i meksidola [A study of certain aspects of the antiarrhythmic action of dimefosfan and mexidol]: Аvtoref. dis. ... kand. med. nauk. Kupavna 2002. (in Russian)
  4. Voronina T.А. Otechestvennyj preparat novogo pokoleniya meksidol, osnovnye ehffekty, mekhanizm dejstviya, primenenie [New domestic drug meksidol, the main effects, mechanism of action, the use]. M 2003. (in Russian)
  5. Voronina T.А. Osnovnye nejropsikhotropnye ehffekty i mekhanizm dejstviya [Basic neuropsychotropic effects and mechanism of action.]. Farmateka 2009; 6: 1-4. (in Russian)
  6. Ganelina I.E., Rodionova V.I., Katyukhin L.N., Teplyakov D.V. Dannye koronarografii i reologicheskikh svojstv ehritrotsitov pri ostrom koronarnom sindrome bez pod"ema segmenta ST [Coronary angiography data and rheological properties of red blood cells in acute coronary syndrome without ST segment elevation]. Kardiologiya 2011; 4: 4-9. (in Russian)
  7. Gar'kin G.G. Sravnitel'naya otsenka kardioprotektornogo ehffekta obzidana, meksidola, ehmoksipina, dimefosfana I preduktala pri ishemii miokarda [Comparative evaluation of the cardioprotective effect of obsidan, mexidol, emoxipine, dimefosfan and preductal in myocardial ischemia]: Аvtoref. dis. … kand. med. nauk. Saransk 2001. (in Russian)
  8. Dolzhenko M.N. Ostryj koronarnyj sindrom: lechenie diabeticheskojdislipidemimii metodom ehterosorbtsii [Acute coronary syndrome: treatment of diabetic dyslipidemia by enterosorption]. Meditsina neotlozhnykh sostoyanij 2007; 3: 63-64. (in Russian)
  9. Kargapolov А.V., Zubareva G.M. Patent RF №2164685 ot 27.03.99. (in Russian)
  10. Lutskij M.А. Аnaliz ehffektivnosti meksidola v kompleksnom lechenii bol'nykh s ishemicheskim insul'tom [Analysis of the mexidol effectiveness in complex treatment of patients with ischemic stroke]. ZHurn nevrol i psikhiatr 2010; 4: 57-59. (in Russian)
  11. Lutskij M.А., Nazarenko E.А., Razinkin K.А. Primenenie otechestvennogo antioksidanta - preparata Meksidol v kompleksnom lechenii ishemicheskogo insul'ta [Application of domestic anti-oxidant - Meksidol drug in treatment of ischemic stroke.]. Ros med zhurn2008; 12: 1661. (in Russian)
  12. Makarova M.YU. Otsenka kardioprotektornogo dejstviya nekotorykh preparatov s antioksidantnoj aktivnost'yu pri sochetaniyakh ehksperimental'nogo diabeta s fizicheskoj na-gruzkoj [Rating of cardioprotective effects of some drugs with antioxidant activity in case of combined experimental diabetes with exercise]. EHksper i klin farmakol 2003; 1: 40-45. (in Russian)
  13. Mari R., Grenner D., Mejes P., Roduehll V. Biokhimiya cheloveka [human biochemistry].V 2-kh t. T. 1. M: Mir 2004; 414. (in Russian)
  14. Mikhin V.P., Mikhajlova T.YU., KHarchenko А.V. i dr. EHffektivnost' prolongirovannykh nitratov u bol'nykhstabil'noj stenokardiej napryazheniya na fone sochetannogo primeneniya meksikora [Effectiveness of prolonged nitrates in patients with stable exertional angina on background of combined application of mexicor]. Klinicheskie issledovaniya lekarstvennykhsredstv v Rossii 2003; 2: 23-26. (in Russian)
  15. Mikhin V.P., Pokrovskij N.V., Gureev V.V. i dr. EHffektivnost' otechestvennogo miokardial'nogo tsitoprotektora I ego farmakodinamika pri ostroj ishemii miokarda: klinicheskie rezul'taty i ehksperimental'nye modeli [Effectiveness of domestic myocardial cytoprotector and its pharmacodynamics in acute myocardial ischemia: clinical results and experimental models]. Ros kardiol zhurn 2011; 2: 37-42. (in Russian)
  16. Nechaeva G.I., Korennova O.YU., Bulakhova E.YU. Ispol'zovanie preparata Meksidol dlya optimizatsii lecheniya arterial'noj gipertenzii u lits molodogo vozrasta [Meksidol drug use to optimize the treatment of hypertension in young adults]. Med vestn 2008; 6-7: 433-434. (in Russian)
  17. Nikol'skaya I.N., KHromova O.M., Irkhina I.S. i dr. Sravnitel'naya otsenka klinicheskoj ehffektivnosti i bezopasnosti preparata meksidol u bol'nykh s OKS pri vklyuchenii vstandartnuyu skhemu terapii [Comparative evaluation of clinical efficacy and safety of meksidol in ACS patients with inclusion in the standard therapeutic regimen]. ZHurn nevrol i psikhiatr 2013; 3: 37-42. (in Russian)
  18. Radushkevich V.L. Klinicheskaya otsenka preparata Meksidol pri lechenii tyazheloj cherepno-mozgovoj travmy na ehtapakh meditsinskoj pomoshhi [Clinical evaluation of the Meksidol in the treatment of severe traumatic brain injury during medical care]. Neotlozhnaya meditsina 2012; 1: 3-6. (in Russian)
  19. Sel'e G. Ocherki adaptatsionnogo sindroma [Essays of adaptation syndrome]. M: Meditsina 1960; 254. (in Russian)
  20. Sidorenko G.I., Komisarova S.M., Zolotukhina S.F., Petrovskaya M.E. Primenenie ehtilmetilgidroksipiridinasuktsinata v lechenii bol'nykh s serdechnoj nedostatochnost'yu [etilmetilgidroksipiridina application in the treatment of patients with heart failure]. Kar-diologiya 2011; 6: 44-48. (in Russian)
  21. Syrov А.V., Zyryanov S.K., Belousov YU.B. Optimizatsiya antikoagulyantnoj terapii u bol'nykh OKS bez pod"ema segmenta ST na osnovanii farmakoehkonomicheskogo analiza [Optimization of anticoagulation therapy in patients with ACS without ST elevation ST on the basis of pharmacoeconomic analysis]. Ros med zhurn 2010; 10: 617-622. (in Russian)
  22. CHerfanova ZH.YU. Otsenka ehffektivnosti primeneniya meksidola v sochetanii s tromboliticheskoj terapiej u bol'nykh s ishemicheskim insul'tom [Evaluating the effectiveness of mexidol in combination with thrombolytic therapy in patients with ischemic stroke]. ZHurn nevrol i psikhiatr 2012; 4: 49-52. (in Russian)
  23. SHpak L.V., Belova N.O. Perspektivnost' primeneniya meksidola v klinicheskoj praktike [Mexidol prospects of application in clinical practice]. Ezhegodnyj sbornik nauchno-prakticheskikh rabot "Obshhie voprosy meditsiny". Tver': Faktor 2010; 131-134. (in Russian)
  24. Fichtlscherer S., Breuer S., Zeiher A.M. Prognostic Value of Systemic Endothelial Dysfunction in Patients With Acute Coronary Syndromes. Further Evidence for the Existence of the "Vulnerable" Patient. Circulation 2004; 110: 1926-1932.
  25. Zweier J.L., Talukder M.A. The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res 2006; 70: 2: 181-190.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.